Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma
- 1 January 2018
- book chapter
- Published by Elsevier BV
- p. 1419-1431.e5
- https://doi.org/10.1016/b978-0-323-35762-3.00087-1
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- Patients With Waldenström Macroglobulinemia Commonly Present With Iron Deficiency and Those With Severely Depressed Transferrin Saturation Levels Show Response to Parenteral Iron AdministrationClinical Lymphoma Myeloma and Leukemia, 2013
- Attainment of complete/very good partial response following rituximab‐based therapy is an important determinant to progression‐free survival, and is impacted by polymorphisms in FCGR3A in Waldenstrom macroglobulinaemiaBritish Journal of Haematology, 2011
- Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signallingNature, 2010
- Site-specific Phosphorylation of CXCR4 Is Dynamically Regulated by Multiple Kinases and Results in Differential Modulation of CXCR4 SignalingOnline Journal of Public Health Informatics, 2010
- Identification of Critical Residues of the MyD88 Death Domain Involved in the Recruitment of Downstream KinasesOnline Journal of Public Health Informatics, 2009
- Identification of Copy Number Abnormalities and Inactivating Mutations in Two Negative Regulators of Nuclear Factor-κB Signaling Pathways in Waldenström's MacroglobulinemiaCancer Research, 2009
- Hepatitis C viral infection is not associated with Waldenström's macroglobulinemiaAmerican Journal of Hematology, 2006
- Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003
- Case 3-1990The New England Journal of Medicine, 1990
- Biologic Activity of Cold-Reacting AutoantibodiesThe New England Journal of Medicine, 1977